Citation: J. Contreras et al., EFFECT OF TREATMENT WITH CARVEDILOL ON INSULIN-RESISTANCE IN NONOBESEMILD-TO-MODERATE HYPERTENSIVE PATIENTS, Journal of hypertension, 16, 1998, pp. 2051-2051
Authors:
SANCHEZMARGALET V
RAMOS E
MATEO J
OLIVAN J
PEREZCANO R
GOBERNA R
Citation: V. Sanchezmargalet et al., NORMAL PANCREASTATIN-LIKE AND INCREASED POST-GLUCOSE INSULIN LEVELS IN YOUNG OFFSPRING OF INSULIN-RESISTANT NONOBESE ESSENTIAL HYPERTENSIVEPATIENTS, Journal of Endocrinology, 153(2), 1997, pp. 313-318
Authors:
CARMENA R
DEOYA M
GOMEZGERIQUE J
MATA P
SERRANO S
FRANCO M
MARTINEZTRIGUERO ML
ALVAREZSALA L
MATESANZ J
RUBIO MJ
GRAS X
OLIVAN J
Citation: R. Carmena et al., PRAVASTATIN, CHOLESTYRAMINE, AND BEZAFIBRATE IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA - THE SPANISH MULTICENTER PRAVASTATIN STUDY, Cardiovascular risk factors, 6(1), 1996, pp. 55-61
Authors:
CURRY CL
ROBINSON H
BROWN R
OLIVAN J
SAMI M
HONOS G
RUDDY TD
BALAZOVJECH I
TOUZEK F
GALINIER F
MARIANI M
DECORDOUE A
BARRANDON S
BRAULT Y
GUEZ D
Citation: Cl. Curry et al., REGRESSION OF LEFT-VENTRICULAR HYPERTROPHY IN PATIENTS WITH ESSENTIAL-HYPERTENSION - RESULTS OF 6-MONTH TREATMENT WITH INDAPAMIDE, American journal of hypertension, 9(8), 1996, pp. 828-832
Authors:
SANCHEZMARGALET V
VALLE M
LOBON JA
MALDONADO A
ESCOBARJIMENEZ F
OLIVAN J
PEREZCANO R
GOBERNA R
Citation: V. Sanchezmargalet et al., INCREASED PLASMA PANCREASTATIN-LIKE IMMUNOREACTIVITY LEVELS IN NONOBESE PATIENTS WITH ESSENTIAL-HYPERTENSION, Journal of hypertension, 13(2), 1995, pp. 251-258
Authors:
SORIANO V
GUTIERREZ M
BRAVO R
DIAZ F
OLIVAN J
GONZALEZLAHOZ J
Citation: V. Soriano et al., SEVERE MYOPATHY IN AN INJECTION-DRUG USER COINFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND HUMAN T-CELL LEUKEMIA-VIRUS TYPE-II, Clinical infectious diseases, 19(2), 1994, pp. 350-351